# NutriSense

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nutrisense

- Industry: Medical Devices & Equipment
- Headquarters: Chicago, US
- Website: www.nutrisense.io
- Total disclosed funding: $28M
- Latest round: Series A (Jun 28, 2022)
- Investors on record: 1

## About

Founded in 2019 by its CEO, Alex Skryl, and based in Illinois, US, NutriSense, Inc. operates as a health technology platform that monitors blood glucose levels. In July 2022, NutriSense, Inc. raised USD 25 million in series A funding led by a new investor, 1315 Capital.

The company offers a digital health care platform that helps users with real-time glucose tracking, meal composition data, fasting and meal timing, physical activity and exercise routines, stress and sleep, and habits and routines.

The company plans to use the July 2022 funding to expand its operations and program.

## Funding rounds

- Series A, Jun 28, 2022, $28M — 1315 Capital

## Investors

- 1315 Capital (https://capitalatlas.ai/funds/1315-capital) — Series A